ROYLE G EENIGENBURG
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- JUNEAU, WI
- NPI
- 1104858836
- Received
- $344,139 in 996 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 297 | $125,926 |
| 2024 | General payment | 191 | $47,094 |
| 2023 | General payment | 174 | $55,518 |
| 2022 | General payment | 133 | $39,594 |
| 2021 | General payment | 62 | $23,023 |
| 2020 | General payment | 25 | $8,603 |
| 2019 | General payment | 114 | $44,379 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Alkermes, Inc. | 231 | $129,768 | 2019–2025 |
| E.R. Squibb & Sons, L.L.C. | 95 | $70,481 | 2024–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 97 | $60,084 | 2020–2025 |
| Teva Pharmaceuticals USA, Inc. | 87 | $51,754 | 2022–2025 |
| Janssen Pharmaceuticals, Inc | 70 | $13,150 | 2019–2025 |
| Allergan, Inc. | 29 | $5,649 | 2019–2020 |
| Indivior Inc. | 14 | $3,794 | 2019–2024 |
| ABBVIE INC. | 70 | $3,783 | 2021–2025 |
| Lundbeck LLC | 102 | $1,593 | 2019–2025 |
| Sunovion Pharmaceuticals Inc. | 15 | $978 | 2019–2021 |
| Otsuka America Pharmaceutical, Inc. | 61 | $800 | 2019–2025 |
| Vanda Pharmaceuticals Inc. | 20 | $426 | 2023–2025 |
| Supernus Pharmaceuticals, Inc. | 24 | $403 | 2023–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $363 | 2022–2025 |
| Neurocrine BioSciences, Inc. | 18 | $293 | 2019–2025 |
| IDORSIA PHARMACEUTICALS US INC | 11 | $191 | 2022–2025 |
| Axsome Therapeutics, Inc. | 9 | $183 | 2023–2025 |
| Corium, LLC | 9 | $136 | 2022–2023 |
| LivaNova USA, Inc. | 1 | $105 | 2024 |
| Collegium Pharmaceutical, Inc. | 6 | $96 | 2025 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $57 | 2019–2021 |
| Noven Therapeutics, LLC | 1 | $22 | 2020 |
| Tris Pharma Inc | 1 | $16 | 2025 |
| Janssen Scientific Affairs, LLC | 1 | $3 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 120 | $263,528 |
| Consulting Fee | 16 | $34,830 |
| Travel and Lodging | 110 | $26,403 |
| Food and Beverage | 740 | $19,015 |
| Education | 10 | $362 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-24 | Alkermes, Inc. | $194 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-12-23 | Alkermes, Inc. | $1,595 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-12-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $136 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-23 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-22 | Collegium Pharmaceutical, Inc. | $16 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-18 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-17 | Otsuka America Pharmaceutical, Inc. | $32 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-16 | Vanda Pharmaceuticals Inc. | $12 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-15 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,080 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-11 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-11 | E.R. Squibb & Sons, L.L.C. | $4 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-08 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $164 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $133 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-03 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-02 | Alkermes, Inc. | $102 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-12-02 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-12-02 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-02 | Teva Pharmaceuticals USA, Inc. | $2 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-12-01 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-01 | Lundbeck LLC | $1 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-30 | Teva Pharmaceuticals USA, Inc. | $420 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-11-28 | E.R. Squibb & Sons, L.L.C. | $7,015 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-26 | Lundbeck LLC | $27 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-11-21 | Vanda Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-20 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $108 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,520 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $130 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,080 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | Otsuka America Pharmaceutical, Inc. | $27 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-05 | E.R. Squibb & Sons, L.L.C. | $158 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-05 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-05 | E.R. Squibb & Sons, L.L.C. | $10 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-04 | E.R. Squibb & Sons, L.L.C. | $434 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-04 | E.R. Squibb & Sons, L.L.C. | $230 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-04 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-04 | Axsome Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-03 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $920 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-21 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-20 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-10-17 | E.R. Squibb & Sons, L.L.C. | $4,140 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-16 | Teva Pharmaceuticals USA, Inc. | $32 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-15 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-15 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | Vanda Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-13 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $825 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $306 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $144 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $65 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $56 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $905 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-08 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-07 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-06 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-02 | E.R. Squibb & Sons, L.L.C. | $289 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-02 | E.R. Squibb & Sons, L.L.C. | $67 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-29 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-24 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-24 | IDORSIA PHARMACEUTICALS US INC | $17 | Food and Beverage | In-kind items and services | Quviviq Drug, Insomnia | 2025 | |
| 2025-09-24 | E.R. Squibb & Sons, L.L.C. | $1 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-23 | Vanda Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-17 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-16 | Alkermes, Inc. | $3 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-09-15 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-11 | Lundbeck LLC | $22 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-09-09 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-09 | Tris Pharma Inc | $16 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-09-09 | Vanda Pharmaceuticals Inc. | $10 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-09-04 | Lundbeck LLC | $8 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-03 | Vanda Pharmaceuticals Inc. | $34 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-02 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-02 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-08-29 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-28 | Alkermes, Inc. | $1,910 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | Vanda Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-26 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-25 | Collegium Pharmaceutical, Inc. | $15 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-20 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-20 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-08-15 | Alkermes, Inc. | $1,910 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-08-15 | Alkermes, Inc. | $800 | Consulting Fee | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-08-13 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-12 | Lundbeck LLC | $6 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-11 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-06 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-05 | Vanda Pharmaceuticals Inc. | $6 | Education | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-04 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | E.R. Squibb & Sons, L.L.C. | $2,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-31 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-31 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-28 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | Lundbeck LLC | $25 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-07-22 | Lundbeck LLC | $0 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-21 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-18 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-15 | IDORSIA PHARMACEUTICALS US INC | $14 | Food and Beverage | In-kind items and services | Quviviq Drug, Insomnia | 2025 | |
| 2025-07-14 | Vanda Pharmaceuticals Inc. | $39 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-07-10 | E.R. Squibb & Sons, L.L.C. | $10 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-09 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-08 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-07 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-03 | Alkermes, Inc. | $1,910 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIVITROL Drug, CNS | 2025 | |
| 2025-07-03 | Teva Pharmaceuticals USA, Inc. | $91 | Education | In-kind items and services | 2025 | ||
| 2025-07-02 | Collegium Pharmaceutical, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-07-01 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-26 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-06-26 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-06-25 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-06-24 | E.R. Squibb & Sons, L.L.C. | $108 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-24 | Vanda Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-24 | Lundbeck LLC | $6 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-23 | E.R. Squibb & Sons, L.L.C. | $40 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-19 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-06-18 | Alkermes, Inc. | $25 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-06-17 | Vanda Pharmaceuticals Inc. | $35 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-10 | Teva Pharmaceuticals USA, Inc. | $3,094 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-06-10 | Teva Pharmaceuticals USA, Inc. | $1,904 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-06-10 | Teva Pharmaceuticals USA, Inc. | $124 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-06-10 | Teva Pharmaceuticals USA, Inc. | $65 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-06-10 | Teva Pharmaceuticals USA, Inc. | $60 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-06-10 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-06-09 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-06-09 | Alkermes, Inc. | $6 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-06-09 | Teva Pharmaceuticals USA, Inc. | $4 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-06-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,980 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-04 | Collegium Pharmaceutical, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-06-03 | Lundbeck LLC | $26 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-03 | E.R. Squibb & Sons, L.L.C. | $8 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-03 | Lundbeck LLC | $1 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-02 | E.R. Squibb & Sons, L.L.C. | $93 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-06-02 | E.R. Squibb & Sons, L.L.C. | $21 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-06-02 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-05-30 | E.R. Squibb & Sons, L.L.C. | $2,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-29 | E.R. Squibb & Sons, L.L.C. | $4,420 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-29 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-27 | E.R. Squibb & Sons, L.L.C. | $371 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-27 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-22 | Alkermes, Inc. | $800 | Consulting Fee | Cash or cash equivalent | VIVITROL Drug, CNS | 2025 | |
| 2025-05-21 | E.R. Squibb & Sons, L.L.C. | $27 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-20 | E.R. Squibb & Sons, L.L.C. | $3,680 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-19 | Lundbeck LLC | $5 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-16 | Alkermes, Inc. | $2,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-05-16 | E.R. Squibb & Sons, L.L.C. | $963 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-05-16 | E.R. Squibb & Sons, L.L.C. | $382 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-05-16 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-05-16 | E.R. Squibb & Sons, L.L.C. | $48 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-05-16 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-05-16 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-05-15 | E.R. Squibb & Sons, L.L.C. | $382 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-05-14 | Vanda Pharmaceuticals Inc. | $34 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-13 | Alkermes, Inc. | $40 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-05-13 | Alkermes, Inc. | $18 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-05-13 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-05-12 | Collegium Pharmaceutical, Inc. | $21 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-05-07 | Takeda Pharmaceuticals U.S.A., Inc. | $16 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-05-06 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 |
The latest 200 records of 996.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Juneau, WI, county Dodge County, WI, state Wisconsin; placed by its city name.
| Measure | Place (city or town) Juneau, WI | County Dodge County, WI | State Wisconsin |
|---|---|---|---|
| Population B01003 | 2,625 | 88,742 | 5,914,872 |
| Population, 2020 census P1 | 2,658 | 89,396 | 5,893,718 |
| Median age B01002 | 43.5 | 43.0 | 40.2 |
| Under 18 B01001 | 14.3% | 19.4% | 21.4% |
| 65 and over B01001 | 17.7% | 19.0% | 18.5% |
| Households B11001 | 864 | 35,910 | 2,479,480 |
| Foreign born B05002 | 6.4% | 2.4% | 5.2% |
| Median household income B19013 | $77,708 | $75,929 | $77,485 |
| Median family income B19113 | $105,132 | $94,523 | $100,141 |
| Per capita income B19301 | $36,660 | $38,304 | $43,373 |
| Poverty rate B17001 | 13.1% | 8.5% | 10.6% |
| Unemployment rate B23025 | 4.6% | 3.8% | 3.2% |
| Civilian labor force B23025 | 1,425 | 47,071 | 3,132,770 |
| Mean commute (minutes) B08013 | 23.8 | 24.1 | 22.2 |
| Bachelor's degree or higher B15003 | 10.1% | 20.3% | 33.4% |
| Housing units B25001 | 893 | 38,524 | 2,778,572 |
| Owner-occupied B25003 | 71.3% | 71.3% | 67.8% |
| Renters B25003 | 28.7% | 28.7% | 32.2% |
| Median home value B25077 | $186,700 | $231,900 | $266,500 |
| Median gross rent B25064 | $852 | $988 | $1,087 |
| White, not Hispanic B03002 | 84.1% | 87.3% | 78.6% |
| Black B03002 | 3.7% | 2.5% | 5.9% |
| Hispanic or Latino B03002 | 10.0% | 6.7% | 8.0% |
| Asian B03002 | 0.6% | 0.5% | 2.9% |
| American Indian and Alaska Native B03002 | 0.4% | 0.3% | 0.5% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Juneau, WI.
Comments